Y Combinator is launching a biotech track
Y Combinator is pulling the curtains off of a new experiment, YC Bio. The idea is to fund early-stage life-sciences companies that are still in the lab phase, YC President Sam Altman wrote on the YC blog today. YC Bio’s first area of focus will be on healthspan and age-related disease. Read More
Sign in to read full story
In order for you to continue reading the full contents of the post, you will need to login first
